Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human CDKN2D Antibodies:
anti-Mouse (Murine) CDKN2D Antibodies:
anti-Rat (Rattus) CDKN2D Antibodies:
Go to our pre-filtered search.
We unexpectedly found that p19INK4d plays an important role in human terminal erythropoiesis
p19(INK4D) is one of the key mediators of miR (show MLXIP Antibodies)-125b activity during the onset of megakaryocyte polyploidization.
p19 may play an important role in the ototoxic effects of cisplatin and is probably involved in the pathogenesis of hearing loss.
MiR (show MLXIP Antibodies)-451 inhibited the proliferation of esophageal squamous cell carcinoma cells by targeting CDKN2D and MAP3K1 (show MAP3K1 Antibodies) expression.
Data indicate that upon oxidative DNA damage, cyclin-dependent kinase (show CDK1 Antibodies) inhibitor p19INK4d strongly binds to and relaxes chromatin.
CDKN2D repression by PML (show PML Antibodies)/RARalpha (show RARA Antibodies) disrupts both cell proliferation and differentiation in the pathogenesis of acute promyelocytic leukemia (show PML Antibodies).
p19-INK4d inhibits neuroblastoma (show ARHGEF16 Antibodies) cell growth, induces differentiation and is hypermethylated and downregulated in MYCN (show MYCN Antibodies)-amplified neuroblastomas.
CDKN2D-WDFY2 (show ZFYVE22 Antibodies) fusion could be an important molecular signature for understanding and classifying sub-lineages among heterogeneous high-grade serous ovarian carcinomas.
Mutations in CDKN2D is associated with sporadic parathyroid adenoma.
P19(INK4d) expression is a poor prognostic factor in ovarian cancer patients.
The expression of three tumor suppressor genes encoded in the INK4/ARF (show CDKN2A Antibodies) locus (p15(INK4b (show CDKN2B Antibodies)), p16(INK4a (show CDKN2A Antibodies)), and p19(ARF (show CDKN2A Antibodies))) was decreased in E6AP (show ube3a Antibodies)(-/-) embryo fibroblasts.
TWIST1 (show TWIST1 Antibodies)-E protein heterodimeric complexes may thus constitute the main active forms of TWIST1 (show TWIST1 Antibodies) with regard to senescence inhibition over the time course of breast tumorigenesis.
Rescue from early-onset hearing loss in a mouse model lacking the cyclin-dependent kinase (show CDK1 Antibodies) inhibitor p19Ink4d.
p19 INK4d controls hematopoietic stem cells in a cell-autonomous manner during genotoxic stress and through the microenvironment during aging
Cdk4 (show CDK4 Antibodies) and Cdk6 (show CDK6 Antibodies) cooperate in hematopoietic tumor development and suggest a role for Cdk6 (show CDK6 Antibodies) in sequestering INK4 (show CDKN2A Antibodies) proteins away from Cdk4 (show CDK4 Antibodies).
Deletion of p19(Ink4d) (p19), a cyclin-dependent kinase (show CDK1 Antibodies) CDK (show CDK4 Antibodies) inhibitor gene, in mice results in spontaneous development of tumors in multiple organs and tissues.
We propose that p19INK4d participates in the cellular mechanisms that trigger senescence by contributing to chromatin compaction
CDK5 (show CDK5 Antibodies)-mediated phosphorylation of p19INK4d avoids DNA damage-induced neurodegeneration in mouse hippocampus and prevents loss of cognitive functions.
an asymmetrical distribution pattern for Cdkn2d transcripts in 2-cell embryos.
Ectopic expression of RUVBL2 (show RUVBL2 Antibodies) decreases the levels of ARF (show CDKN2A Antibodies), whereas knockdown of RUVBL2 (show RUVBL2 Antibodies) results in a marked increase in ARF (show CDKN2A Antibodies) levels. In addition, RUVBL2 (show RUVBL2 Antibodies) down-regulates the levels of p53 (show TP53 Antibodies) in an ARF (show CDKN2A Antibodies)-dependent manner.
The protein encoded by this gene is a member of the INK4 family of cyclin-dependent kinase inhibitors. This protein has been shown to form a stable complex with CDK4 or CDK6, and prevent the activation of the CDK kinases, thus function as a cell growth regulator that controls cell cycle G1 progression. The abundance of the transcript of this gene was found to oscillate in a cell-cycle dependent manner with the lowest expression at mid G1 and a maximal expression during S phase. The negative regulation of the cell cycle involved in this protein was shown to participate in repressing neuronal proliferation, as well as spermatogenesis. Two alternatively spliced variants of this gene, which encode an identical protein, have been reported.
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)
, cyclin-dependent kinase 4 inhibitor D
, Cyclin-dependent kinase 4 inhibitor D
, CDK inhibitor p19INK4d
, cell cycle inhibitor, Nur77 associating protein
, cyclin-dependent kinase 4 inhibitor D p19
, inhibitor of cyclin-dependent kinase 4d